In 2018, biobanking for research purposes was estimated at $2.2bn. The overall biobanking market is estimated to grow at a CAGR of 6.6% in the first half of the forecast period. The use of biobanks for therapeutic applications is also increasing, such as in the stem cell banking sector.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 276-page report you will receive 77 tables and 84 figures– all unavailable elsewhere.
The 276-page report provides clear detailed insight into the biobanking market. Discover the key drivers and challenges affecting the market.
Report Scope
• Number of samples banked, revenues and growth forecasts from 2019 to 2029 for the global biobanking market
• Number of samples banked, revenues and growth forecasts from 2019 to 2029 for the global biobanking market by application:
• Biobanking for research
• Biobanking for therapeutic use
• Number of samples banked, revenues and growth forecasts from 2019 to 2029 for the research segment:
• Human tissues: Commercial, Public Sector
• Stem cells
• Other applications
• Number of samples banked, revenues and growth forecasts from 2019 to 2029 for the therapeutic applications segment:
• Umbilical cord stem cell banking
• Adult stem cell banking
• Revenues and growth forecasts from 2019 to 2029 for the biobanking market by product:
• Consumables
• Equipment: Freezers & Refrigerators, Cryogenic Storage Systems, Incubators & Centrifuges, Thawing Equipment, Temperature Control Systems, Alarms & Monitoring Systems
• Services
• Revenue and growth forecasts from 2019 to 2029 for the global biobanking market by regional and national market:
• The US and Japan
• Leading EU countries – Germany, France, the UK, Italy, Spain and the Netherlands
• The BRIC countries – Brazil, Russia, India and China
• Discussion and profiles of the leading players in the biobanking industry. This report also provides a list of leading companies for each of the biobanking submarket.
• Provides and overview of technology used by biobanks. This includes systems, software, consumables and services. Prominent companies providing services are also discussed.
• Qualitative analyses of the biobanking industry, including industry trends, drivers and restrains, a SWOT analysis, a STEP analysis and Porter’s Five Forces analysis of the biobanking market.
• Key Questions Answered by this Report:
• How is the biobanking market evolving?
• What is driving and restraining biobanking market dynamics?
• How will each biobanking submarket segment grow over the forecast period and how much revenues will these submarkets account for in 2029?
• How will market shares of each biobanking submarket develop from 2018-2029?
• Which biobanking submarket will be the main driver of the overall market from 2018-2029?
• How will market shares of the national markets change by 2029 and which nation will lead the market in 2029?
• Who are the leading players?
• How will the sector evolve as alliances form during the period between 2018 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the biobanking market. You find data, trends and predictions.
Buy our report today Biobanking Market Forecasts 2019-2029: Research, Therapeutic, Human Tissue, Stem Cells, Commercial Sector, Public Sector, Umbilical Cord Banking, Adult Stem Cell Banking, Consumables, Equipment, Services, Freezers & Refrigerators, Cryogenic Storage Systems, Incubators & Centrifuges, Thawing Equipment, Temperature Control Systems, Alarms & Monitoring Systems.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Biobanking for Therapeutics: World Market Review 2018 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 Harmonization of Bio Banking and Initiatives Taken by Various Organizations
2.8 Biobank Funding and Financial Sustainability
2.9 The Guidelines and Standards for Biobanking
2.10 Laws and Regulations for Biobank-Based Research
2.10.1 HIPAA Amendments
2.11 Biobanking and the Pharmaceutical Industry
2.11.1 Biobanking in Research, Drug Discovery and Development
2.11.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.11.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.11.1.3 Biomarker Discovery in Drug Development
2.11.2 Biobanking for Therapeutic Purposes
2.11.3 Biobanking in Clinical Trials
3. Global Biobanking Market 2019 to 2029
3.1 The World Biobanking Market in 2018
3.2 Biobanking for Therapeutics: Research vs. Therapeutics in 2024 and 2029
3.3 World Biobanking Market: Overarching Revenue Forecast 2019 to 2029
3.4 Biobanks Stored More Than 1.5 Billion Specimens in 2018
3.5 The Biobanking for Therapeutics Market by Sector: Grouped Revenue Forecasts 2019 to 2029
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2019 to 2029
3.6.2 Driving Forces: Outweighs Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2019 to 2029
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2019 to 2029
4. Biobanking for Research Purposes: World Market 2019 to 2029
4.1 Breakdown of Biobanking for Research Market by Tissue Type, 2018
4.2 Biobanking for Research in 2024 and 2029: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2019 to 2029
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2018
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2019 to 2029
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2019 to 2029
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2019 to 2029
4.8 The Stem Cell Banking Market for Research in 2018
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2019 to 2029
4.9.1 R&D- Growing Interest Towards iPSCs
4.10 Banking of Other Biologics Specimens for Research in 2018
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2019 to 2029
5. Stem Cell Banking for Future Therapeutic Use: World Market 2019 to 2029
5.1 Stem Cell Banking for Therapeutic Use in 2018: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2024 and 2029
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cells Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2018
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2019 to 2029
5.7 The Adult Stem Cell Banking Market in 2018
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2019 to 2029
6. Global Biobanking Market by Product 2019 to 2029
6.1 The World Biobanking Market by Product in 2018
6.2 Biobanking Market by Product: 2024 and 2029
6.3 Consumables Market: Overarching Revenue Forecast 2019 to 2029
6.4 Equipment Market: Overarching Revenue Forecast 2019 to 2029
6.5 Services Market: Overarching Revenue Forecast 2019 to 2029
7. Leading National Markets 2019 to 2029
7.1 The Geographical Footprint of Biobanking
7.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
7.1.2 Biobanks in the US: A Fragmented Picture
7.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
7.2 Biobanking for Therapeutics: The US Led the Way in 2018
7.3 The Leading National Markets: Grouped Revenue Forecasts 2019 to 2029
7.4 How Will Regional Market Shares Change to 2029?
7.5 The US Biobanking Market 2019 to 2029: Diversifying and Expanding
7.6 The Top European Biobanking Markets 2019 to 2029: Leading the Way in Biobanking Infrastructure
7.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
7.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
7.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
7.6.4 UK: Limited Presence of Biobanking Networks
7.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
7.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
7.7 The Japanese Biobanking Market 2019 to 2029: A High Level of Government Investment Drives Growth
7.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2019 and 2029
7.8.1 The Chinese Biobanking Market 2019 to 2029: The High Rate of Growth Will Continue
7.8.2 The Indian Biobanking Market 2019 to 2029: Set to Become the Leading Market for Private Stem Cell Banking?
7.8.3 The Brazilian Biobanking Market 2019 to 2029: Will New Regulations Drive or Restrain the Market?
7.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, can this be Overcome?
8. Technology for Biobanking: Systems, Software, Consumables, and Services Associated with Biobanking
8.1 The Biobanking-Associated Market: Overview
8.2 Systems Technology: Fully Automated Handling
8.2.1 Automated Liquid Handling Systems
8.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
8.2.3 Automated DNA Isolation
8.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
8.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
8.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
8.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
8.3.4 Automated Storage and Retrieval Systems: Essential Technology
8.3.5 RFID and Tagging Technology: Advantages over Barcodes
8.4 Software for Biobanks
8.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
8.4.2 LIMS Functions
8.5 Consumables: High Quality Required for Effective Sample Management
8.5.1 Addressing Sample Storage and Tracking Issues
8.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
9. Leading Companies in the Biobanking Market, 2018
9.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
9.2 Leading Vendors of Biobanking Market 2018
9.2.1 Thermo Fisher Scientific, Inc.
9.2.1.1 Thermo Fisher Scientific: Financials 2015-2018
9.2.1.2 Strategic Developments
9.2.2 Merck KGaA
9.2.2.1 Merck KGaA: Financials 2015-2018
9.2.2.2 Strategic Developments
9.2.3 Qiagen
9.2.3.1 Qiagen: Financials 2015-2018
9.2.4 Danaher
9.2.4.1 Danaher: Financials 2015-2018
9.2.4.2 Strategic Developments
9.3 Commercial Biobanks for Research Purposes in 2018
9.3.1 Tissue Solutions: A Virtual Biobank with a Global Presence
9.3.2 An Overview of the Products and Services Offered by Tissue Solutions
9.3.3 Banked Samples Occur in Many Formats
9.3.4 Prospective Tissue Collection for Hard-to-Find Samples
9.3.5 Fresh Samples from Surgical Resections are in High Demand
9.3.6 Freshly Isolated Human Cells are a Valuable Research Tool
9.3.7 FDA/EMA Panel of Normal Tissues
9.3.8 Strengths, Capabilities and the Future Outlook for Tissue Solutions
9.3.9 Asterand Bioscience is now Part of Stemgent
9.3.9.1 Asterand’s Products and Services: XpressBANK, BioSpoke and PhaseZERO
9.3.9.2 The Future Outlook for Asterand
9.3.10 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
9.3.10.1 Services from Biopta: A Variety of Lab Services and Fresh Tissue Sample Procurement
9.3.10.2 The First Catalogue of Assays Based on Human Functional Tissues
9.3.10.3 The Future Outlook for Biopta: Fresh Tissue Will Be in Demand
9.3.11 BioServe: One of the World’s Largest Commercial Biorepositories
9.3.11.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
9.3.11.2 The Future Outlook for BioServe
9.3.12 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
9.13.2.1 Features of and Recent Developments at Coriell Biobank
9.3.12.2 Future Outlook for the Coriell Biobank
9.4 Prominent Biobanks for Therapeutic Use in 2018
9.4.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
9.4.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
9.4.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
9.4.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
9.4.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
9.4.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
9.4.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company Will Be Promoted by New Parent Company
9.4.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
9.4.9 StemLife is Reportedly Facing Challenges due to Government Regulations in Malaysia
9.4.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
9.4.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
9.4.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
10. Qualitative Analysis of the Biobanking Market 2019 to 2029
10.1 Industry Trends
10.1.1 The Growing Demand for Biobank Resources for Research
10.1.2 The Establishment of Biobanking Networks
10.1.2.1 BBMRI: The Most Extensive Biobank Network
10.1.3 Virtual Biobanks: Connecting a Fragmented Industry
10.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
10.1.5 Automated Biobanking Has Become Imperative
10.1.6 Increasing Uptake of LIMS
10.1.7 Green Banking – Becoming More Energy Efficient
10.2 The Strengths and Weaknesses of the Biobanking Market in 2017
10.2.1 HBS are Valuable Resources for R&D
10.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
10.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
10.2.4 The Effect of Big Data on Biobanking
10.2.5 Insufficient Accessible Numbers of High Quality Biospecimens
10.2.6 Biobanks are Fragmented and Uncoordinated
10.2.7 Lack of Standardisation is a Weakness of the Industry
10.2.8 Lack of Public Awareness Limits Number of Donors
10.2.9 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
10.3 Opportunities and Threats Facing the Biobanking Market, 2019 to 2029
10.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
10.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
10.3.3 Biobanking Networks as a Basis for Personalised Medicine
10.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
10.3.5 Even with Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long-Term
10.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
10.3.7 Limitations Surrounding Informed Consent
10.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2019 to 2029
10.5 Porters Five Forces Analysis, 2019 to 2029
10.5.1 Bargaining Power of Supplier: Low
10.5.2 Bargaining Power of Buyer: Moderate
10.5.3 Competitive Rivalry: High
10.5.4 Threat of New Entrants: Moderate
10.5.5 Threat of Substitutes: Low
11. Conclusion
11.1 World Biobanking Market 2019 to 2029: High Revenue Growth Predicted
11.2 Biobanking for Research 2019 to 2029: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2019 to 2029: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples - Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver and a Need for Strategic Planning for Sustainability
11.5.3 Marked Challenges, but Opportunities for Expansion
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 2.1 Prominent Population-Based Biobanks, 2018
Table 2.2 Prominent Disease-Based Biobanks, 2018
Table 2.3 Guidelines and Recommendations for Biobanks, 2018
Table 2.4 Laws and Other Regulations for Biobank-Based Research by Country/ Organisation 2018
Table 2.5 Pharmaceutical and Biotechnology Companies with In-House Biobanks, 2018
Table 3.1 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Revenue ($mn) and Market Share (%), 2018
Table 3.2 Biobanking for Research vs. Therapeutics: Revenues ($m), Market Share (%) in 2024 and 2029
Table 3.3 Global Biobanking Market: Revenue Forecast ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 3.4 The No. of Samples Stored in Biobanks by Purpose: Overall World Forecast No. Of Samples (bn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 3.5 Global Biobanking Market by Application: Revenue Forecasts ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 3.6 Biobanking Market for Research Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 3.7 Biobanking for Therapeutic Use Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.1 The Biobanking for Research Market by Tissue Type: Revenues ($mn) and Market Shares (%), 2018
Table 4.2 Biobanking for Research by Tissue Type: A Comparison of Revenues ($mn) and Market Shares (%), 2024 and 2029
Table 4.3 Biobanking for Research by Tissue Type: Grouped Forecasts, Revenue ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.4 Number of Research Samples Banked: Overall World Forecast, No. of Samples (m), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.5 The Human Tissue Banking Market Forecast: Revenue ($mn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.6 The Commercial vs. Public Sector Human Tissue Banking Market: Comparison of Revenues ($mn) and Market Share (%), 2018, 2024 and 2029
Table 4.7 Commercial Human Tissue Banking Forecast, Revenue ($mn) Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.8 Commercial Human Tissue Banking Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.9 Prominent Commercial Human Tissue Banks, 2018
Table 4.10 Public Sector Human Tissue Banking Forecast: Revenue ($mn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.11 Prominent Public-Funded Human Tissue Banks, 2018
Table 4.12 The Stem Cell Banking Market for Research Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.13 Prominent Stem Cell Banks Serving the Research Community, 2018
Table 4.14 Banking of Other Biologic Specimens for Research Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 4.15 Prominent Biobanks Storing Other Biologic Samples, 2018
Table 5.1 Biobanking for Therapeutic Use by Stem Cell Type: Market Share (%), 2018
Table 5.2 Biobanking for Therapeutic Use by Stem Cell Type: Comparison of Revenues ($mn) and Market Share (%), 2024 and 2029
Table 5.3 Global Therapuetics Market by Stem Cells Type Revenue Forecasts ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 5.4 The Number of Stem Cell Samples Banked for Therapeutic Use: Overall World Forecast, No. of Samples (m), Annual Growth (%), CAGR (%), 2018 to 2029
Table 5.5 Prominent Public and Private Cord Blood Banks, 2018
Table 5.6 The Umbilical Cord Banking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2018
Table 5.7 Prominent Companies in the Adult Stem Cell Banking Industry, 2018
Table 5.8 The Adult Stem Cell Banking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 6.1 Global Biobanking Industry by Product: Revenue ($mn) and Market Share (%), 2018
Table 6.2 Biobanking Market by Product: 2024 and 2029
Table 6.3 Global Biobanking Consumables Market: Revenue Forecast ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 6.4 Global Biobanking Equipment Market: Revenue Forecast ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 6.5 Global Biobanking Services Market: Revenue Forecast ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.1 Breakdown of BBMRI Network Directory Members by Country, 2018
Table 7.2 The Leading National Biobanking Markets: Comparison of Revenues ($mn) and Market Shares (%), 2018
Table 7.3 Leading National Markets Grouped Forecasts: Revenue ($mn), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.4 Leading National Markets: Comparison of Market Share (%), 2018, 2024 and 2029
Table 7.5 US Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.6 The Leading European Markets for Biobanking Grouped Forecasts: Revenue ($mn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.7 Examples of Biobanking Initiatives Funded by the European Commission, 2018
Table 7.8 Germany Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.9 French Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.10 Italy Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.11 UK Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.12 Spain Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.13 Prominent Clinical and Population Biobanks in the Netherlands, 2018
Table 7.14 The Netherlands Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.15 Japan Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.16 The Biobanking Industry in the BRIC Countries Grouped Forecasts: Revenue ($mn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.17 Chinese Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.18 Indian Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.19 Prominent Research Biobanks in India, 2018
Table 7.20 Brazilian Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 7.21 Russian Biobanking Market Forecast: Revenue ($mn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2029
Table 8.1 Prominent Companies Providing Automated Liquid Handling Technology, 2018
Table 8.2 Prominent Companies Providing Room Temperature Storage Solutions, 2018
Table 8.3 Prominent Companies Providing Ultra-Low Temperature Freezers (-80°C), 2018
Table 8.4 Mechanical Freezing vs. Liquid Nitrogen: Comparison of Advantages and Disadvantages, 2018
Table 8.5 Prominent Companies Providing Cryogenic Storage Solutions, 2018
Table 8.6 Prominent Providers of Automated Biobanking Systems, 2018
Table 8.7 Major Vendors in the LIMS Market, 2018
Table 8.8 Prominent Vendors of Consumables for Biobanking, 2018
Table 8.9 Prominent Biorepository Service Providers, 2018
Table 9.1 Prominent Players in the Biobanking Industry for Research, 2018
Table 9.2 Prominent Companies in the Stem Cell Banking Industry for Therapeutic Use, 2018
Table 9.3 China Cord Blood Corp: Revenue ($ 000’), Total Units Stored for Subscribers, and No. Of New Subscribers, 2016 to 2018
Table 9.4 StemLife: Comparison of Revenue ($m) between 2015 and 2016
Table 10.1 Strengths and Weaknesses of the Biobanking Industry, 2018
Table 10.2 Opportunities and Threats Facing the Biobanking Industry, 2018 to 2029
Table 10.3 Social, Technological, Economic and Political (STEP) Forces Influencing the Biobanking Industry, 2018 to 2029
List of Figures
Figure 1.1 Global Biobanking Industry Segmentation Overview, 2018
Figure 2.1 Processes Involved in Biobanking, 2018
Figure 2.2 The Classification of Biobanks, 2018
Figure 3.1 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Share (%), 2018
Figure 3.2 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Shares (%), 2024
Figure 3.3 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Shares (%), 2029
Figure 3.4 Global Biobanking Market: Revenue Forecast ($mn) & Annual Growth (%), 2018 to 2029
Figure 3.5 The No. of Samples Stored in Biobanks by Purpose: Overall World Forecast, No. of Samples (bn), 2018 to 2029
Figure 3.6 Global Biobanking Market by Application: Revenue Forecasts ($mn), 2018 to 2029
Figure 3.7 Biobanking Market for Research: Revenue Forecast ($mn) & Annual Growth (%), 2018 to 2029
Figure 3.8 Biobanking for Research: Drivers and Restraints, 2019 to 2029
Figure 3.9 Biobanking for Therapeutic Use: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 3.10 Biobanking for Therapeutic Use: Drivers and Restraints, 2019 to 2029
Figure 4.1 The Biobanking for Research Market by Tissue Type: Market Share (%), 2018
Figure 4.2 Biobanking for Research by Tissue Type: Market Shares (%), 2024
Figure 4.3 Biobanking for Research by Tissue Type: Market Shares (%), 2029
Figure 4.4 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts ($mn), 2018 to 2029
Figure 4.5 Biobanking for Research: Market Drivers and Restraints, 2019 to 2029
Figure 4.6 Number of Research Samples Banked: Overall World Forecast, No. of Samples (m), 2019 to 2029
Figure 4.7 The Human Tissue Banking Market: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 4.8 Human Tissue Banking for Research: Market Drivers and Restraints, 2019 to 2029
Figure 4.9 The Commercial vs. Public Sector Human Tissue Banking Market: Market Shares (%), 2018
Figure 4.10 The Commercial vs. Public Sector Human Tissue Banking Market: Market Shares (%), 2024
Figure 4.11 The Commercial vs. Public Sector Human Tissue Banking Market: Market Share (%), 2029
Figure 4.12 The Human Tissue Banking Market by Subsector: Revenue Forecasts ($mn), 2018 to 2029
Figure 4.13 Commercial Human Tissue Banking: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 4.14 Public Sector Human Tissue Banking: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 4.15 The Stem Cell Banking Market for Research: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 4.16 Stem Cell Banking for Research: Market Drivers and Restraints, 2019 to 2029
Figure 4.17 Banking of Other Biologic Specimens for Research: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 4.18 Biobanking of Other Biologic Specimens for Research: Market Drivers and Restraints, 2019 to 2029
Figure 5.1 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2018
Figure 5.2 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2024
Figure 5.3 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2029
Figure 5.4 Biobanking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts ($mn), 2018 to 2029
Figure 5.5 The Number of Stem Cell Samples Banked for Therapeutic Use (m): Forecast 2019 to 2029
Figure 5.6 The Stem Cell Banking Market for Future Therapeutic Use: Drivers and Restraints, 2019 to 2029
Figure 5.7 The Umbilical Cord Banking Market: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 5.8 The Umbilical Cord Blood Banking Market: Drivers and Restraints, 2019 to 2029
Figure 5.9 The Adult Stem Cell Banking Market: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 5.10 The Adult Stem Cell Banking Market: Drivers and Restraints, 2019 to 2029
Figure 6.1 Global Biobanking Industry by Product: Market Share (%), 2018
Figure 6.2 Biobanking Industry by Product: Market Shares (%), 2024
Figure 6.3 Biobanking By Product: Market Shares (%), 2029
Figure 6.4 Global Biobanking Consumables Market: Revenue Forecast ($mn) & Annual Growth (%), 2018 to 2029
Figure 6.5 Global Biobanking Equipment Market: Revenue Forecast ($mn) & Annual Growth (%), 2018 to 2029
Figure 6.6 Global Biobanking Services Market: Revenue Forecast ($mn) & Annual Growth (%), 2018 to 2029
Figure 7.1 The Leading National Biobanking Markets: Market Shares (%), 2018
Figure 7.2 The Leading National Markets: Grouped Revenue Forecasts ($mn), 2018 to 2029
Figure 7.3 The Leading National Markets: Market Share (%), 2024
Figure 7.4 The Leading National Markets: Market Share (%), 2029
Figure 7.5 US Biobanking Market: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.6 Driving and Restraining Factors of the US Biobanking Market, 2019 to 2029
Figure 7.7 The Leading European Markets for Biobanking: Grouped Revenue Forecasts ($mn), 2018 to 2029
Figure 7.8 Biobanking in the Leading European Countries: Driving and Restraining Factors, 2019 to 2029
Figure 7.9 The German Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.10 The French Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.11 The Italian Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.12 The UK Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.13 The Spanish Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.14 The Netherlands Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.15 The Japanese Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.16 Driving and Restraining Factors Influencing the Japanese Biobanking Industry, 2019 to 2029
Figure 7.17 The Biobanking Industry in the BRIC Countries: Grouped Revenue Forecasts ($mn), 2018 to 2029
Figure 7.18 Driving and Restraining Factors of the Biobanking Industry in the BRIC Countries, 2019 to 2029
Figure 7.19 The Chinese Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.20 The Indian Biobanking Industry: Revenue ($mn) Forecast, 2019 to 2029
Figure 7.21 The Brazilian Biobanking Market: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 7.22 The Russian Biobanking Industry: Revenue Forecast ($mn) & AGR (%), 2018 to 2029
Figure 8.1 Structure of the Biobanking Industry: Biobanking-Associated Market, Biobanks and End Users, 2018
Figure 8.2 The Basic Function of LIMS
Figure 9.1 Biobanking Business Model: Commercial Sourcing of Biological Samples, 2018
Figure 9.2 Business Model: Commercial Banking of Biological Samples, 2018
Figure 9.3 Thermo Fisher Scientific: Revenue ($bn) 2015-2018
Figure 9.4 Merck KGaA: Revenue ($bn) 2015-2018
Figure 9.5 Qiagen: Revenue ($bn) 2015-2018
Figure 9.6 Danaher: Revenue ($bn) 2015-2018
Figure 9.7 China Cord Blood Corp: Revenue ($ ‘000), 2016 to 2018
Figure 9.8 StemLife: Comparison of Revenue ($m), 2015 and 2016
Figure 10.1 Porters Five Forces Analysis, 2019 to 2029
Figure 11.1 The Global Biobanking Market by Application: Market Share (%) 2018-2029
Figure 11.2 Biobanking for Research by Sample Type: Comparison of Revenues ($mn), 2018, 2024 and 2029
Figure 11.3 Therapeutic Market by Type: Comparison of Revenues ($mn), 2018, 2024 and 2029
Figure 11.4 Leading Regional Markets for Biobanking: Comparison of Revenue Share (%), 2018-2029
Abbott Laboratories
Accelrys
Adnexus Therapeutics
AIS
AKH Biobank
AllCells
AlloSource
American CryoStem
American Type Culture Collection (ATCC)
Amgen
Amsterdam Medical Centre
Analytical Biological Services
ARUP Laboratories
ASPREE Healthy Ageing Biobank
AssureImmune
Asterand Bioscience
AstraZeneca
Aurora Biomed
Autoscribe Informatics
AuxoCell Laboratories
AXM Shenyang
Bangalore Brain Bank
Barts Gynae Tissue Bank
Bayer
BBMRI
Beckman Coulter
Beckman Coulter Diagnostics
BioCells
BioCision
BioFortis
Biogen Idec
Biogenea
BioLife Solutions
Biomatrica
Biopta
BioreclamationIVT (BioIVT)
BioRep
BioRepository Resources
BioServe Biotechnologies
BioStorage Technologies
Biovault Technical
BIOVIA
BrainNet Europe
Bristol-Myers Squibb
Brooks Automation
Brooks Life Science Systems
Broos Automation
Caladrius Biosciences
California Cryobank Stem Cell Services LLC
Cambridge Biomedical Research Centre
Cambridge Biosciences
Cancer Genetics Inc.
Cancer Human Biobank (caHUB)
CARTaGENE
CCLG Tissue Bank
Celgene Cellular Therapeutics
Cells4Life
Celltex Therapeutics
Cellular Dynamics
Cepheid
Cesca Therapeutics
Chernobyl Tissue Bank
China Cord Blood Corporation
China Kadoorie Biobank
China Stem Cells
CMD Biobank
CONCOR
Copper Merger Sub, Inc.
CorCell
Cord Blood America
Cord Blood Registry (CBR)
Cordlife
CordVida
CORE Informatics
Coriell Institute for Medical Research
Covance
Cryo Bio System
Cryo-Cell International
Cryogenetics
CryoLogic
Cryopraxis
Cryo-Save
Cryotherm GmbH
Cureline
Custom Biogenic Systems
Cybrdi
Danaher
deCODE Genetics
Deloitte
Diversified Mortgage Investors, Inc.
East-West Bio
Eli Lilly
Estonian Genome Project
Fisher BioServices
Fox Chase Cancer Centre
Future Health Biobank
Future Health Biobank
GE Healthcare
Genentech
Genome Quebec Biobank
GenVault
GlaxoSmithKline (GSK)
Golden Meditech Holdings
Hamilton Company
Hamilton Robotics
Hamilton Storage Technologies
Harvard Stem Cell Institute
Hospital Necker Paris
Human Longevity Inc.
Hungarian Biobank
Huntington Disease Biobank
Imperial Tissue Bank
Inbiomed
Indivumed
Infectious Disease Biobank
IntegenX
International Stem Cell Corporation
Kaiser Permanente
King's College London Tissue Bank
LABVANTAGE
Labware
LBD Life Sciences Ltd.
Leiden Longevity
Leiden University Medical Centre
LifeBank USA
LifeCell Femme
LifeGene
LifeLines Biobank
Malmӧ Microbiology Biobank
MatriCal Bioscience
Merck KGaA
Mitochondrial Disease Biobank
Mitronic
Merck Sharp & Dohme (MSD)
Nanjing Xinjiekou Department Store Co.
Narayana Hrudayalaya Tissue Bank and Stem Cell Research Center
NeoStem
NESDA
Netherlands Twin Registry
NHS Blood and Transplant Cord Blood Bank
Novare Biologistics
Novartis
Ocimum Biosolutions
OriGene
Pacific BioStorage
PALGA
Panasonic Biomedical
Parelsnoer
Patheon N.V.
PerkinElmer
Pfizer
Pharma Cells
Pharmacells Group
Pharmagene
Popgen
Pop-Gen National Cohort
Precious Cells Biobank
Precision Bioservices
PrecisionMed
PREVEND
Progenicyte
Progenitor Cell Therapy (PCT)
ProMedDx
ProteoGenex
Qiagen
ReproCELL Group Company
Riken BRC Cell Bank
Roche
Sanofi
Sapien Biosciences
Sartorius Stedim Biotech
Scéil
Seattle Genetics
SeqWright Genomic Services
Singapore Cord Blood Bank
Smart Cells
Stanford Tissue Bank
StarLIMS
Steelgate
Stellacure
STEMCELL Technologies Inc.
StemCyte
Stemgent
StemLife
StemSave
Swedish Institute for Infectious Disease Control Biobank
System Biosciences
TAP Biosystems
Tata Memorial Hospital Tissue Bank
TCG Life Sciences Tissue Bank
Tecan
The Cambridge Brain Bank
The Guangzhou Biobank
The National Cancer Tissue Bank
Indian Institute of Technology
Thermo Fisher Scientific
Thermo Scientific
ThermoGenesis
Tissue Solutions
Titan Pharmaceuticals
Totipotent
TTP Labtech
UCL Biobank
UK Biobank
UK ME-CFS Biobank
UK Multiple Sclerosis Tissue Bank
UK Parkinson's Disease Tissue Bank
UK Stem Cell Bank
US Biomax
ViaCord
VidaPlus
Wisconsin International Stem Cell (WiCell) Bank
List of Organizations Mentioned in the Report
American Association of Tissue Banks
Australasian Biospecimen Network (ABN)
Bavarian Red Cross (BRK)
Biobank Ireland Trust
Centro Nazionale per le Risorse Biologiche (CNRB)
Coriell Institute for Medical Research
European Association for Predictive, Preventative & Personalised Medicine (EPMA)
European Health Risk Monitoring (EHRM)
Food and Drug Administration (FDA)
Harvard University
INSERM
Instituto de Salud Carlos III
International Agency for Research on Cancer (IARC)
International Air Transport Association (IATA)
International Society for Biological and Environmental Repositories (ISBER)
National Cancer Institute (NCI)
National Genome Research Network (NGFN)
National Institutes of General Medical Sciences
Northeastern University
Office of Biorepositories and Biospecimen Research (OBBR)
RAND
Russian Society for Biobanking and Biopreservation (RSBB)
Sechenov First Moscow Medical University (SFMMU)
Singapore Biobank (SBB)
Singapore Tissue Network (STN)
Spanish Ministry of Science and Innovation (MICINN)
Spanish National Biobank Network
The Organisation for Economic Co-operation and Development (OECD)
UK Biobank
University of Manchester
University of Tuebingen
US Department of Transportation (DOT)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
